Nuwellis (NUWE) Stock Analysis
NASDAQHealthcareMedical - Devices
Track NUWE in your portfolio for free · Portfolio tracker
What Nuwellis does
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Key metrics
ETFs linked to NUWE
Broad-market and Healthcare sector ETFs an investor holding Nuwellis is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how NUWE fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze NUWE in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Nuwellis?
- Nuwellis trades under the ticker NUWE on NASDAQ.
- Which exchange is NUWE listed on?
- NUWE is listed on NASDAQ.
- What sector does Nuwellis operate in?
- Nuwellis is classified in the Healthcare sector (Medical - Devices industry).
- How can PortView help analyze NUWE in a portfolio?
- PortView shows NUWE's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.